Related Experiment Videos
Clinical experience with sulbactam/ampicillin in the treatment of obstetric and gynecologic infections. Rio de
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A comparison of ampicillin plus sulbactam versus clindamycin and gentamicin for treatment of postpartum infection.
Supplement to International journal of gynecology and obstetrics·1989
Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
Supplement to International journal of gynecology and obstetrics·1989
Abortion laws and policies: challenges and opportunities.
Supplement to International journal of gynecology and obstetrics·1989
Preventing and managing complications of induced abortion in Third World countries.
Supplement to International journal of gynecology and obstetrics·1989
The significance and scope of reproductive tract infections among Third World women.
Supplement to International journal of gynecology and obstetrics·1989
Control of pain for women undergoing abortion.
Supplement to International journal of gynecology and obstetrics·1989
Comparative plaque- and liquid-based phage susceptibility testing of Pseudomonas aeruginosa isolates in a cystic fibrosis randomized clinical trial.
Journal of clinical microbiology·2026
Clinical impact of a rapid urine diagnostic algorithm combined with antimicrobial stewardship in patients with suspected urinary sepsis.
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2026
Preoperative Antibiotic Administration Before Distal Radius Fracture ORIF and Postoperative Outcomes: A Propensity-Matched Cohort Study.
Journal of hand surgery global online·2026
Findings on the efficacy of sonic debridement in chronic wound management - a case series.
Journal of tissue viability·2026
Exploring the evidence for use of cefiderocol as part of combination therapies: a systematic review of in vitro, in vivo, and clinical studies.
Journal of global antimicrobial resistance·2026